The Effect of Skin Color Scale Material Used by Families at Home in the Postnatal Period on the Process of Hospital Admission Due to Jaundice and Breastfeeding Parameters

Trial statusNot yet recruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age36-42
SponsorIstanbul University - Cerrahpasa

About this trial

The aim of this research is to evaluate the effect of the Skin Color Scale Material used by families in the postnatal period on the hospital admission process due to jaundice and breastfeeding parameters.

Although neonatal jaundice is mostly physiological, it can lead to serious complications such as kernicterus if not detected in time. Visually supported educational materials developed to provide early awareness can help families both to regularly monitor the baby's skin color and to notice the signs of jaundice in time.

Eligibility criteria

This trial accepts healthy volunteers

Qualifiers

Preterm infants born alive between 36-42 weeks of gestation or delivered healthy to their mothers,

Newborns with a birth weight of 2500 grams or more,

Newborns without a history of multiple pregnancy (twins, triplets, etc.),

Newborns with at least one literate parent,

Disqualifiers

Newborns younger than 36 weeks and requiring intensive care, or newborns older than 42 weeks,

Newborns weighing less than 2500 grams at birth,

Newborns requiring postnatal intensive care,

Newborns with congenital anomalies, metabolic diseases, or serious clinical problems,

Trial design

Design model

Crossover

Treatments tested in this trial

  • Experiment Group

    Other intervention

    The Skin Color Scale Material (S-CARD / Neonatal Jaundice Monitoring Card) developed by the researcher and its user guide will be provided; verbal and visual training on the use of the material will be provided. Parents will be asked to observe their baby's skin color for the first 7 days after birth and record it on the monitoring card.

  • control group

    Other intervention

    Families in this group will only receive routine, verbal information from the unit upon discharge. Both groups will be monitored similarly, but training on the use of the Skin Color Scale Material (S-CARD / Neonatal Jaundice Monitoring Card) will only be given to the experimental group.

Treatment groups

128 Participants
are divided into 2 treatment groups
Group A: The group using the Skin Color Scale Material (S-CARD / Neonatal Jaundice Monitoring Card).Experimental treatment 1 intervention
Group B: Group not using Skin Color Scale Material (S-CARD / Neonatal Jaundice Monitoring Card)Active comparator 1 intervention

Trial outcomes

Primary outcomes

1

Data Collection Form

Developed by the researcher and their consultant in line with the literature (source). It is a form consisting of 34 questions. Participants' demographic characteristics, obstetric history, and information regarding childbirth will be obtained through this form.

Time frame
One month

Secondary outcomes

1

Bristol Lactation Assessment Tool (BEDS)

This is a form developed by Jenny Ingram in 2014 and validated in Turkish by Dolgun et al. in 2018. The application time for the scale is 5-10 minutes. While the Cronbach alpha value of the original form of the instrument was found to be 0.68, it was found to be 0.77 in the Turkish adaptation study. Scoring of the scale: Each item is scored between 0-2 points. The lowest score obtained from the scale is 0, and the highest score is 8. It will be used to evaluate the breastfeeding success of babies. This instrument covers parameters such as breastfeeding frequency, duration, time of initiation of breastfeeding, and the general condition of the baby.

Time frame
one month
2

Newborn Monitoring Form

This is a chart consisting of 7 questions developed by the researcher and their advisor in line with the literature. Data regarding the clinical follow-up period of the infants included in the study will be recorded in this form.

Time frame
one month
3

S-card Parent Feedback Evaluation Form:

It is a form consisting of 14 questions developed by the researcher and his/her advisor in line with the literature.

Time frame
one month

Other outcomes

Locations

This trial has no locations.

Sponsors and contacts

Click on the lead sponsor to view all of their trials.

This trial is not recruiting at the moment. You can still explore other options: